Neil Cashman - Nov 18, 2024 Form 4 Insider Report for ProMIS Neurosciences Inc. (PMN)

Role
Chief Scientific Officer, Director
Signature
/s/ Max A. Milbury, Attorney-in-Fact
Stock symbol
PMN
Transactions as of
Nov 18, 2024
Transactions value $
$0
Form type
4
Date filed
11/20/2024, 07:02 PM
Previous filing
Oct 30, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PMN Option (right to buy) Award $0 +200K $0.00 200K Nov 18, 2024 Common Shares 200K $1.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to this option shall vest on November 18, 2025, and the balance shall vest ratably over 36 months.